TQ Quiz | Oculosystemic Diseases and the Drugs that Treat Them (Nashville 2025) by Events@optometricedu.com | Oct 22, 2025 | 2025 Nashville, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 90 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. Which of the following patients is most likely to have plaquenil maculopathy?* A - A 95-pound female that has been on 400mg/day for 25 years B - A 305-pound male that has been on 400mg/day for 25 years C - A 145-pound female that has been on 400mg/day for 3 years D - A 110-pound female that has been on 200mg/day for 35 years 2. What is the most common cause of death in the United States?* A - Stroke B - Myocardial infarction C - Cancer D - Pneumonia 3. Bilateral involvement in patients with ocular ischemic syndrome may occur in up to __________ percent of cases.* A - 5%. B - 20%. C - 42%. D - 58%. 4. The most common etiology of ocular ischemic syndrome is severe unilateral or bilateral atherosclerotic disease of the _______________.* A - Internal carotid artery B - Vertebral artery C - Posterior cerebral artery D - Brachial artery 5. What is the most commonly used non-invasive imaging test to detect carotid occlusive disease?* A - Trans-thoracic echocardiography B - Magnetic resonance angiography (MRA) C - Multi-focal electroretinography D - Duplex (Doppler) carotid ultrasonography 6. A granulomatous disease is characterized by an organized collection of ______________.* A - Macrophages B - Eosinophils C - Histamine D - Tumor cells 7. In the ocular ischemic syndrome/hypoperfusion retinopathy, the majority of hemorrhages occur in which area of the retina?* A - Mid-periphery B - Posterior pole C - Far periphery D - Fovea 8. The eye is an extension of ____________________.* A - The brain and central nervous system B - The skeletal system C - The digestive system D - The excretory system 9. Which patient is most likely to have sarcoidosis?* A - 9-year-old black female B - 28-year-old black female C - 28-year-old white male D - 55-year-old white female 10. Which of the following best describes sarcoidosis?* A - A cardiac disease B - A pulmonary disease C - A multi-system disease D - An ocular disease 11. Which factor is least likely to contribute to the development of hypertension?* A - sex B - ethnicity C - iris color D - age 12. You perform blood pressure on a 55-year old Hispanic male during a comprehensive eye examination. The results are 135/90 mmHg RAS @ 3:35PM. What should you do next?* A - enucleate the right eye B - refer to the Emergency Room STAT! C - finish the exam and have patient to schedule an appointment with his PCP within 2 months D - perform gonioscopy 13. Hypertensive choroidopathy may be characterized by __________.* A - Sub-retinal neovascularization B - Schie’s line C - Drusen D - Elschnig’s spots 14. Which of the following is a common ocular manifestation of high blood pressure?* A - flame shaped hemes B - vitreomacular traction syndrome (VMTS) C - angle closure glaucoma D - drusen 15. The best ocular treatment/management approach for patients with Stage 1-2 hypertensive retinopathy is ___________.* A - Ranibizumab (Lucentis) intravitreal injection B - Laser photocoagulation C - Systemic hypertension management (blood pressure control) D - Vitrectomy 16. Your type 2 diabetes patient was recently prescribed semaglutide (Ozempic). Which of the following will she most likely experience?* A - PSC Cataract B - Mild-moderate abdominal pain C - Ketoacidosis D - Acquired unilateral headache 17. How does metformin work?* A - It limits the liver's ability to release sugar and improves sensitivity to insulin B - It inhibits carbonic anhydrase C - It causes the release of insulin as blood sugar levels are rising D - It causes weight gain in people with diabetes and dyslipidemia 18. Your patient has a history of rheumatoid arthritis, but is taking no meds. She presents to you with scleritis. What is the current mainstay for the treatment of her scleritis?* A - topical nonsteroidal anti-inflammatory drugs (NSAIDs) B - oral immunosuppressants C - oral antibiotics D - oral corticosteroids 19. Which of the following adverse effects is most likely to occur in a patient on oral prednisone?* A - weight gain B - retinal detachment C - weight loss D - pupil miosis 20. Central serous chorioretinopathy can result from using which class of drugs?* A - Beta-blockers B - Corticosteroids C - Antihistamines D - Prostaglandins Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeNashville 2025 - Identifying and Managing Pharmaceutical Complications*After 90 days, pricing will increase to $30. Price: Retake Discount Price: Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
